Statement of Principles concerning malignant neoplasm of the testis and paratesticular tissues No. 15 of 2004

Overview

The Instrument No. 15 of 2004, enacted under the Veterans' Entitlements Act 1986, addresses the need to update and replace the previous Statement of Principles concerning malignant neoplasm of the testis and paratesticular tissues. The Repatriation Medical Authority revoked Instrument No. 3 of 1997 and established a new Statement of Principles to better align with the latest medical-scientific evidence. The policy objective is to ensure that veterans who have served and developed malignant neoplasm of the testis and paratesticular tissues, or who have died from such conditions, receive appropriate recognition and benefits. The new Statement of Principles specifies that the only factor related to the cause of or material contribution to these conditions, which can be related to relevant service, is the inability to obtain appropriate clinical management during service. This legislative instrument aims to clarify and streamline the criteria for veterans' entitlements in these specific medical circumstances.

Scope and Application

This legislative instrument, issued under the Veterans’ Entitlements Act 1986, concerns the revocation and determination of the Statement of Principles relating to malignant neoplasm of the testis and paratesticular tissues, including death from such conditions. The Act applies to all matters covered by section 120A of the Act, thereby affecting veterans and their dependants who have been diagnosed with or have died from malignant neoplasm of the testis and paratesticular tissues. The instrument clarifies that the definition of "malignant neoplasm of the testis and paratesticular tissues" excludes certain types of cancers such as soft tissue sarcoma, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma, focusing instead on primary malignant neoplasms arising from specified testicular and paratesticular tissues. The instrument specifies the relevant ICD-10-AM codes for these conditions and establishes that the only factor that can be related to service for the purpose of this Statement of Principles is the inability to obtain appropriate clinical management. The scope of the Act extends to operational, peacekeeping, and hazardous service, thus encompassing a broad range of military activities. Any subordinate instruments or regulations that may further define or extend the application of this legislation are not specified in this particular instrument.

Key Provisions

The legislative instrument primarily serves to revoke Instrument No. 3 of 1997 and introduces a new Statement of Principles concerning malignant neoplasm of the testis and paratesticular tissues under the Veterans’ Entitlements Act 1986 (section 1). This new Statement of Principles outlines the circumstances under which such conditions may be related to relevant military service, providing a framework for veterans' claims related to these conditions (section 2). It specifies that the relevant condition is a primary malignant neoplasm arising from the cells of the testis or paratesticular tissues, excluding certain other cancers and sarcomas (section 2(b)). The instrument also defines relevant terms, such as "relevant service" and "terminal event," to clarify the scope of the legislation (section 5). Under this legislation, the Repatriation Medical Authority is tasked with examining the available medical-scientific evidence to determine the factors that may relate to the cause of or materially contribute to malignant neoplasm of the testis and paratesticular tissues or death from such conditions in the context of relevant service (section 3). The Authority has concluded that the only factor related to relevant service is the inability to obtain appropriate clinical management for the condition (section 4). This determination is pivotal for veterans seeking to establish a connection between their service and their health condition, thereby qualifying for entitlements under the Act. The legislation imposes specific obligations on veterans and their representatives, requiring them to provide evidence supporting their claim that they were unable to obtain appropriate clinical management for the condition during their service. This includes medical records and other documentation that substantiates the claim (section 6). Additionally, the Repatriation Medical Authority is obligated to review the provided evidence thoroughly, applying the criteria set out in the new Statement of Principles to determine the validity of the claim. Failure to comply with these requirements may result in the denial of the claim. Breach of the obligations set out in this legislation may result in various consequences. While the instrument does not explicitly outline specific offences, non-compliance with the requirements for providing evidence or misrepresentation of facts in a claim could be considered fraudulent. Such conduct may lead to civil or criminal penalties, including fines or imprisonment, depending on the severity of the breach. The maximum penalties for such offences would be determined in accordance with the general provisions of the Veterans’ Entitlements Act 1986 and other relevant legislation. The intent behind the penalties is to ensure the integrity of the veterans' claims process and to protect the entitlements of eligible veterans.